{"nct_id":"NCT04138927","title":"A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia","status":"ENROLLING_BY_INVITATION","status_verified_date":"2021-07","start_date":"2019-10-30","start_date_type":"ACTUAL","primary_completion_date":"2024-04","primary_completion_date_type":"ESTIMATED","completion_date":"2024-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["RIGL"]}